Search in:

Journal of Inflammation Research Volume 11, 2018 - Issue

Submit an article Journal homepage

Open access

124

Views

CrossRef citations to date

Altmetric

Original Research

Glucagon-like peptide-1 exerts anti-inflammatory effects on mouse colon smooth muscle cells through the cyclic adenosine monophosphate/nuclear factor-κB pathway in vitro

Ahmed Al-Dwairi1 Department of Physiology and Biochemistry, Faculty of Medicine, Jordan University of Science and Technology, Irbid, JordanCorrespondence[email protected]

Tamara E Alqudah1 Department of Physiology and Biochemistry, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan

Othman Al-Shboul1 Department of Physiology and Biochemistry, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan

Mohammad Alqudah1 Department of Physiology and Biochemistry, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan

Ayman G Mustafa2 Department of Anatomy, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan

Mahmoud A Alfaqih1 Department of Physiology and Biochemistry, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan

Pages 95-109 | Published online: 20 Mar 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (18)

Syed Faizan Mehdi, Suma Pusapati, Muhammad Saad Anwar, Durga Lohana, Parkash Kumar, Savitri Aninditha Nandula, Fatima Kausar Nawaz, Kevin Tracey, Huan Yang, Derek LeRoith, Michael J. Brownstein & Jesse Roth. (2023) Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Frontiers in Immunology 14.
Crossref

Konstantinos Arvanitakis, Theocharis Koufakis, Djordje Popovic, Giuseppe Maltese, Omar Mustafa, Michael Doumas, Olga Giouleme, Kalliopi Kotsa & Georgios Germanidis. (2023) GLP-1 Receptor Agonists in Obese Patients with Inflammatory Bowel Disease: from Molecular Mechanisms to Clinical Considerations and Practical Recommendations for Safe and Effective Use. Current Obesity Reports 12:2, pages 61-74.
Crossref

Angelo Avogaro, Saula Vigili de Kreutzenberg, Mario Luca Morieri, Gian Paolo Fadini & Stefano Del Prato. (2022) Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history. The Lancet Diabetes & Endocrinology 10:12, pages 882-889.
Crossref

Shiying Shao, Xiaoling Zhang, Qinqin Xu, Ruping Pan & Yong Chen. (2022) Emerging roles of Glucagon like peptide-1 in the management of autoimmune diseases and diabetes-associated comorbidities. Pharmacology & Therapeutics 239, pages 108270.
Crossref

Nyan Abdalqadir & Khosrow Adeli. (2022) GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk. Microorganisms 10:10, pages 2061.
Crossref

Yuan Zhang, Na Shi, Lun He, Shanshan Wang, Xin Li, Shenzhou Lu, Qiqing Zhang & Haitao Niu. (2021) Silk Sericin Activates Mild Immune Response and Increases Antibody Production. Journal of Biomedical Nanotechnology 17:12, pages 2433-2443.
Crossref

Maria Angela Guzzardi, Gabriella Pugliese, Filomena Bottiglieri, Caterina Pelosini, Giovanna Muscogiuri, Luigi Barrea, Silvia Savastano & Annamaria Colao. (2021) Obesity-related gut hormones and cancer: novel insight into the pathophysiology. International Journal of Obesity 45:9, pages 1886-1898.
Crossref

Shabnam Radbakhsh, Stephen L. Atkin, Luis E. Simental-Mendia & Amirhossein Sahebkar. (2021) The role of incretins and incretin-based drugs in autoimmune diseases. International Immunopharmacology 98, pages 107845.
Crossref

Jenna Elizabeth Hunt, Jens Juul Holst, Palle Bekker Jeppesen & Hannelouise Kissow. (2021) GLP-1 and Intestinal Diseases. Biomedicines 9:4, pages 383.
Crossref

Brent A McLean, Chi Kin Wong, Jonathan E Campbell, David J Hodson, Stefan Trapp & Daniel J Drucker. (2021) Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation. Endocrine Reviews 42:2, pages 101-132.
Crossref

Chin-Hsiao Tseng. (2021) Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus. Journal of Crohn's and Colitis 15:1, pages 64-73.
Crossref

Yoshiyuki Mishima & Shunji Ishihara. (2020) Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome. International Journal of Molecular Sciences 21:22, pages 8664.
Crossref

Luiza P. Géa, Eduarda D. da Rosa, Bruna S. Panizzutti, Érica Z. de Aguiar, Larissa F. de Oliveira, Pamela Ferrari, Angelo Piato, Rosane Gomez, Rafael Colombo & Adriane R. Rosa. (2020) Reduction of hippocampal IL-6 levels in LPS-injected rats following acute exendin-4 treatment. Naunyn-Schmiedeberg's Archives of Pharmacology 393:7, pages 1303-1311.
Crossref

Adrian Bartoszek, Ee Von Moo, Agata Binienda, Adam Fabisiak, Julia B. Krajewska, Paula Mosińska, Karolina Niewinna, Aleksandra Tarasiuk, Kirill Martemyanov, Maciej Salaga & Jakub Fichna. (2020) Free Fatty Acid Receptors as new potential therapeutic target in inflammatory bowel diseases. Pharmacological Research 152, pages 104604.
Crossref

Weizhuo Zheng, Haile Pan, Li Wei, Feng Gao & Xiaozong Lin. (2019) Dulaglutide mitigates inflammatory response in fibroblast-like synoviocytes. International Immunopharmacology 74, pages 105649.
Crossref

Kanwal Rehman, Mehwish Bagh Ali & Muhammad Sajid Hamid Akash. (2019) Genistein enhances the secretion of glucagon-like peptide-1 (GLP-1) via downregulation of inflammatory responses. Biomedicine & Pharmacotherapy 112, pages 108670.
Crossref

Ahmed Al‑Dwairi, Mohammad Alqudah, Othman Al‑Shboul, Mahmoud Alfaqih & Dana Alomari. (2018) Metformin exerts anti‑inflammatory effects on mouse colon smooth muscle cells in�vitro. Experimental and Therapeutic Medicine.
Crossref

Yong Chen, Shiying Shao, Xiaoling Zhang, Qinqin Xu & Ruping Pan. (2022) Glucagon Like Peptide-1: More than Glucose Control and Weight Reduction. SSRN Electronic Journal.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Glucagon-like peptide-1 exerts anti-inflammatory effects on mouse colon smooth muscle cells through the cyclic adenosine monophosphate/nuclear factor-κB pathway in vitro

Articles from other publishers (18)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Glucagon-like peptide-1 exerts anti-inflammatory effects on mouse colon smooth muscle cells through the cyclic adenosine monophosphate/nuclear factor-κB pathway in vitro

Citations (18)

Articles from other publishers (18)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date